PKR is activated in MDS patients and its subcellular localization depends on disease severity

Abstract

1 Flohr T, Schrauder A, Cazzaniga G, Panzer-Grümayer R, van der Velden V, Fischer S et al. Minimal residual disease (MRD)-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia (ALL… (More)
DOI: 10.1038/leu.2008.122

Topics

3 Figures and Tables

Slides referencing similar topics